Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 218145, 15 pages
http://dx.doi.org/10.1155/2013/218145
Review Article

The Role of Thyroid Hormones as Inductors of Oxidative Stress and Neurodegeneration

Departamento de Fisiología, Escuela Nacional de Ciencias Biológicas, IPN. Prol. Carpio y Plan de Ayala, s/n, 11340 México City, DF, Mexico

Received 18 September 2013; Accepted 8 November 2013

Academic Editor: Sathyasaikumar V. Korrapati

Copyright © 2013 I. Villanueva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Zs-Nagy, “On the true role of oxygen free radicals in the living state, aging, and degenerative disorders,” Annals of the New York Academy of Sciences, vol. 928, pp. 187–199, 2001. View at Google Scholar · View at Scopus
  2. G. Barja, “Oxygen radicals, a failure or a success of evolution?” Free Radical Research Communications, vol. 18, no. 2, pp. 63–70, 1993. View at Google Scholar · View at Scopus
  3. A. W. Linnane, S. Marzuki, T. Ozawa, and M. Tanaka, “Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases,” The Lancet, vol. 1, no. 8639, pp. 642–645, 1989. View at Google Scholar · View at Scopus
  4. A. T. Diplock, “Antioxidants and disease prevention,” Molecular Aspects of Medicine, vol. 15, no. 4, pp. 293–376, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Lenaz, “Role of mitochondria in oxidative stress and ageing,” Biochimica et Biophysica Acta, vol. 1366, no. 1-2, pp. 53–67, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. B. A. Freeman and J. D. Crapo, “Biology of disease. Free radicals and tissue injury,” Laboratory Investigation, vol. 47, no. 5, pp. 412–426, 1982. View at Google Scholar · View at Scopus
  7. B. Chance, H. Sies, and A. Boveris, “Hydroperoxide metabolism in mammalian organs,” Physiological Reviews, vol. 59, no. 3, pp. 527–605, 1979. View at Google Scholar · View at Scopus
  8. K. Staniek and H. Nohl, “Are mitochondria a permanent source of reactive oxygen species?” Biochimica et Biophysica Acta, vol. 1460, no. 2-3, pp. 268–275, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Chance and G. R. Williams, “Respiratory enzymes in oxidative phosphorylation—III. The steady state,” The Journal of Biological Chemistry, vol. 217, no. 1, pp. 409–427, 1955. View at Google Scholar · View at Scopus
  10. A. Boveris and B. Chance, “The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen,” Biochemical Journal, vol. 134, no. 3, pp. 707–716, 1973. View at Google Scholar · View at Scopus
  11. P. Ježek and L. Hlavatá, “Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 12, pp. 2478–2503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Panov, S. Dikalov, N. Shalbuyeva, R. Hemendinger, J. T. Greenamyre, and J. Rosenfeld, “Species- and tissue-specific relationships between mitochondrial permeability transition and generation of ROS in brain and liver mitochondria of rats and mice,” American Journal of Physiology: Cell Physiology, vol. 292, no. 2, pp. C708–C718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. V. P. Skulachev, “Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants,” Quarterly Reviews of Biophysics, vol. 29, no. 2, pp. 169–202, 1996. View at Google Scholar · View at Scopus
  14. A. Boveris and E. Cadenas, “Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone,” IUBMB Life, vol. 50, no. 4-5, pp. 245–250, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. B. P. Yu, “Cellular defenses against damage from reactive oxygen species,” Physiological Reviews, vol. 74, no. 1, pp. 139–162, 1994. View at Google Scholar · View at Scopus
  16. D. Filipović and M. B. Radojčić, “CuZn superoxide dismutase in the hippocampus and brain cortex of rats exposed to various stress conditions,” Annals of the New York Academy of Sciences, vol. 1048, pp. 366–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Lontz, A. Sirsjo, W. Liu, M. Lindberg, O. Rollman, and H. Torma, “Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1β and TNF-α,” Free Radical Biology and Medicine, vol. 18, no. 2, pp. 349–355, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Asayama, K. Dobashi, H. Hayashibe, Y. Megata, and K. Kato, “Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism,” Endocrinology, vol. 121, no. 6, pp. 2112–2118, 1987. View at Google Scholar · View at Scopus
  19. K. Das and G. B. N. Chainy, “Thyroid Hormone influences antioxidant defense system in adult rat brain,” Neurochemical Research, vol. 29, no. 9, pp. 1755–1766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. T. S. Scanlan, K. L. Suchland, M. E. Hart et al., “3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone,” Nature Medicine, vol. 10, no. 6, pp. 638–642, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. G. Ianculescu and T. S. Scanlan, “3-Iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology?” Molecular BioSystems, vol. 6, no. 8, pp. 1338–1344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Saba, G. Chiellini, S. Frascarelli et al., “Tissue distribution and cardiac metabolism of 3-iodothyronamine,” Endocrinology, vol. 151, no. 10, pp. 5063–5073, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Lanni, M. Moreno, A. Lombardi, and F. Goglia, “Calorigenic effect of diiodothyronines in the rat,” Journal of Physiology, vol. 494, no. 3, pp. 831–837, 1996. View at Google Scholar · View at Scopus
  24. P. Venditti, G. Napolitano, L. Di Stefano et al., “Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity,” Molecular and Cellular Endocrinology, vol. 341, no. 1-2, pp. 55–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. L. Schwartz and J. H. Oppenheimer, “Ontogenesis of 3,5,3′-triiodothyronine receptors in neonatal rat brain: dissociation between receptor concentration and stimulation of oxygen consumption by 3,5,3′-triiodothyronine,” Endocrinology, vol. 103, no. 3, pp. 943–948, 1978. View at Google Scholar · View at Scopus
  26. M. J. Dauncey, “Thyroid hormones and thermogenesis,” Proceedings of the Nutrition Society, vol. 49, no. 2, pp. 203–215, 1990. View at Google Scholar · View at Scopus
  27. A. M. Adamo, S. F. Llesuy, J. M. Pasquini, and A. Boveris, “Brain chemiluminescence and oxidative stress in hyperthyroid rats,” Biochemical Journal, vol. 263, no. 1, pp. 273–277, 1989. View at Google Scholar · View at Scopus
  28. S. S. Katyare and R. R. Rajan, “Influence of thyroid hormone treatment on the respiratory activity of cerebral mitochondria from hypothyroid rats. A critical re-assessment,” Experimental Neurology, vol. 195, no. 2, pp. 416–422, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Horrum, R. B. Tobin, and R. E. Ecklund, “Thyroxine-induced changes in rat liver mitochondrial cytochromes,” Molecular and Cellular Endocrinology, vol. 41, no. 2-3, pp. 163–169, 1985. View at Google Scholar · View at Scopus
  30. M. A. Horrum, R. B. Tobin, and R. E. Ecklund, “Thyroxine-induced changes in rat liver mitochondrial ubiquinone,” Biochemical and Biophysical Research Communications, vol. 138, no. 1, pp. 381–386, 1986. View at Google Scholar · View at Scopus
  31. P. Venditti, A. Puca, and S. Di Meo, “Effects of thyroid state on H2O2 production by rat heart mitochondria: sites of production with Complex I- and Complex II-linked substrates,” Hormone and Metabolic Research, vol. 35, no. 1, pp. 55–61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Fernandez, X. Barrientos, and K. Kipreos, “Superoxide radical generation, NADPH oxidase activity, and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation,” Endocrinology, vol. 117, no. 2, pp. 496–501, 1985. View at Google Scholar · View at Scopus
  33. Y. Ueta, A. Levy, H. S. Chowdrey, and S. L. Lightman, “Hypothalamic nitric oxide synthase gene expression is regulated by thyroid hormones,” Endocrinology, vol. 136, no. 10, pp. 4182–4187, 1995. View at Google Scholar · View at Scopus
  34. C. S. Bangur, J. L. Howland, and S. S. Katyare, “Thyroid hormone treatment alters phospholipid composition and membrane fluidity of rat brain mitochondria,” Biochemical Journal, vol. 305, no. 1, pp. 29–32, 1995. View at Google Scholar · View at Scopus
  35. R. Gredilla, M. López Torres, M. Portero-Otín, R. Pamplona, and G. Barja, “Influence of hyper- and hypothyroidism on lipid peroxidation, unsaturation of phospholipids, glutathione system and oxidative damage to nuclear and mitochondrial DNA in mice skeletal muscle,” Molecular and Cellular Biochemistry, vol. 221, no. 1-2, pp. 41–48, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Kanner, J. B. German, and J. E. Kinsella, “Initiation of lipid peroxidation in biological systems,” Critical Reviews in Food Science and Nutrition, vol. 25, no. 4, pp. 317–364, 1987. View at Google Scholar · View at Scopus
  37. L. Oziol, P. Faure, C. Vergely, L. Rochette, Y. Artur, and P. Chomard, “In vitro free radical scavenging capacity of thyroid hormones and structural analogues,” Journal of Endocrinology, vol. 170, no. 1, pp. 197–206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. O. V. Galkina, V. M. Prokopenko, F. E. Putilina, N. D. Eshchenko, and A. V. Arutyunyan, “The effects of thyroxine isomers on free-radical oxidation processes in subcellular fractions of rat cerebral cortex,” Neuroscience and Behavioral Physiology, vol. 31, no. 4, pp. 463–465, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Venditti, M. Balestrieri, S. Di Meo, and T. De Leo, “Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues,” Journal of Endocrinology, vol. 155, no. 1, pp. 151–157, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Fernandez, S. Llesuy, L. Solari, K. Kipreos, L. A. Videla, and A. Boveris, “Chemiluminescent and respiratory responses related to thyroid hormone-induced liver oxidative stress,” Free Radical Research Communications, vol. 5, no. 2, pp. 77–84, 1988. View at Google Scholar · View at Scopus
  41. A. S. D. R. Araujo, M. F. S. De Miranda, U. De Oliveira et al., “Increased resistance to hydrogen peroxide-induced cardiac contracture is associated with decreased myocardial oxidative stress in hypothyroid rats,” Cell Biochemistry and Function, vol. 28, no. 1, pp. 38–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Shinohara, T. Mano, A. Nagasaka et al., “Lipid peroxidation levels in rat cardiac muscle are affected by age and thyroid status,” Journal of Endocrinology, vol. 164, no. 1, pp. 97–102, 2000. View at Google Scholar · View at Scopus
  43. D. K. Sahoo, A. Roy, S. Bhanja, and G. B. N. Chainy, “Hypothyroidism impairs antioxidant defence system and testicular physiology during development and maturation,” General and Comparative Endocrinology, vol. 156, no. 1, pp. 63–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. G. Dulloo and S. Samec, “Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered,” British Journal of Nutrition, vol. 86, no. 2, pp. 123–139, 2001. View at Google Scholar · View at Scopus
  45. A. Nègre-Salvayre, C. Hirtz, G. Carrera et al., “A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation,” FASEB Journal, vol. 11, no. 10, pp. 809–815, 1997. View at Google Scholar · View at Scopus
  46. K. S. Echtay, D. Roussel, J. St-Plerre et al., “Superoxide activates mitochondrial uncoupling proteins,” Nature, vol. 415, no. 6867, pp. 96–99, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Rousset, M.-C. Alves-Guerra, J. Mozo et al., “The biology of mitochondrial uncoupling proteins,” Diabetes, vol. 53, no. 1, supplement, pp. S130–S135, 2004. View at Google Scholar · View at Scopus
  48. A. S. R. Araujo, M. F. M. Ribeiro, A. Enzveiler et al., “Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism,” Molecular and Cellular Endocrinology, vol. 249, no. 1-2, pp. 133–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Mogulkoc, A. K. Baltaci, L. Aydin, E. Oztekin, and A. Sivrikaya, “The effect of thyroxine administration on lipid peroxidation in different tissues of rats with hypothyroidism,” Acta Physiologica Hungarica, vol. 92, no. 1, pp. 39–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S. S. Popov, A. N. Pashkov, T. N. Popova, V. I. Zoloedov, A. V. Semenikhina, and T. I. Rakhmanova, “Oxidative status and citrate concentration in rat tissues during experimental hyperthyroidism and melatonin treatment,” Bulletin of Experimental Biology and Medicine, vol. 144, no. 2, pp. 203–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Guerrero, R. Pamplona, M. Portero-Otín, G. Barja, and M. López-Torres, “Effect of thyroid status on lipid composition and peroxidation in the mouse liver,” Free Radical Biology and Medicine, vol. 26, no. 1-2, pp. 73–80, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Messarah, A. Boumendjel, A. Chouabia et al., “Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats,” Experimental and Toxicologic Pathology, vol. 62, no. 3, pp. 301–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Pamplona, M. Portero-Otín, C. Ruiz et al., “Thyroid status modulates glycoxidative and lipoxidative modification of tissue proteins,” Free Radical Biology and Medicine, vol. 27, no. 7-8, pp. 901–910, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Venditti, A. Bari, L. Di Stefano, and S. Di Meo, “Tri-iodothyronine treatment differently affects liver metabolic response and oxidative stress in sedentary and trained rats,” Journal of Endocrinology, vol. 197, no. 1, pp. 65–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Giris, Y. Erbil, B. Depboylu et al., “Heme oxygenase-1 prevents hyperthyroidism induced hepatic damage via an antioxidant and antiapoptotic pathway,” Journal of Surgical Research, vol. 164, no. 2, pp. 266–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Chattopadhyay, D. K. Sahoo, U. Subudhi, and G. B. N. Chainy, “Differential expression profiles of antioxidant enzymes and glutathione redox status in hyperthyroid rats: a temporal analysis,” Comparative Biochemistry and Physiology C, vol. 146, no. 3, pp. 383–391, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. U. Subudhi, K. Das, B. Paital, S. Bhanja, and G. B. N. Chainy, “Alleviation of enhanced oxidative stress and oxygen consumption of l-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin,” Chemico-Biological Interactions, vol. 173, no. 2, pp. 105–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Morini, E. Casalino, C. Sblano, and C. Landriscina, “The response of rat liver lipid peroxidation, antioxidant enzyme activities and glutathione concentration to the thyroid hormone,” International Journal of Biochemistry, vol. 23, no. 10, pp. 1025–1030, 1991. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Rey, D. Roussel, C. Romestaing et al., “Up-regulation of avian uncoupling protein in cold-acclimated and hyperthyroid ducklings prevents reactive oxygen species production by skeletal muscle mitochondria,” BMC Physiology, vol. 10, no. 1, article 5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. M. T. De Sibio, R. A. Luvizotto, R. M. Olimpio et al., “A comparative genotoxicity study of a supraphysiological dose of triiodothyronine (T3) in obese rats subjected to either calorie-restricted diet or hyperthyroidism,” PLoS ONE, vol. 8, no. 2, Article ID e56913, 2013. View at Google Scholar
  61. T. Pan, M. Zhong, X. Zhong, Y. Zhang, and D. Zhu, “Levothyroxine replacement therapy with vitamin E supplementation prevents oxidative stress and cognitive deficit in experimental hypothyroidism,” Endocrine, vol. 43, no. 2, pp. 434–439, 2013. View at Google Scholar
  62. V. S. Reddy, S. Gouroju, M. M. Suchitra et al., “Antioxidant defense in overt and subclinical hypothyroidism,” Hormone and Metabolic Research, vol. 45, no. 10, pp. 754–758, 2013. View at Google Scholar
  63. B. Makay, O. Makay, C. Yenisey et al., “The interaction of oxidative stress response with cytokines in the thyrotoxic rat: is there a link?” Mediators of Inflammation, vol. 2009, Article ID 391682, 7 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Santi, M. M. Duarte, C. C. de Menezes, and V. L. Loro, “Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism,” International Journal of Endocrinology, vol. 2012, Article ID 856359, 7 pages, 2012. View at Publisher · View at Google Scholar
  65. J. Sewerynek, J. Wiktorska, D. Nowak, and A. Lewinski, “Methimazole protection against oxidative stress induced by hyperthyroidism in graves' disease,” Endocrine Regulations, vol. 34, no. 2, pp. 83–89, 2000. View at Google Scholar · View at Scopus
  66. L. Dumitriu, R. Bartoc, H. Ursu, M. Purice, and V. Ionescu, “Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism,” Endocrinologie, vol. 26, no. 1, pp. 35–38, 1988. View at Google Scholar · View at Scopus
  67. A. Saad-Hussein, H. Hamdy, H. M. Aziz, and H. Mahdy-Abdallah, “Thyroid functions in paints production workers and the mechanism of oxidative-antioxidants status,” Toxicology and Industrial Health, vol. 27, no. 3, pp. 257–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Santi, M. M. M. F. Duarte, R. N. Moresco et al., “Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism,” Clinical Chemistry and Laboratory Medicine, vol. 48, no. 11, pp. 1635–1639, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Aslan, N. Cosar, H. Celik et al., “Evaluation of oxidative status in patients with hyperthyroidism,” Endocrine, vol. 40, no. 2, pp. 285–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. M. J. Coria, A. I. Pastrán, and M. S. Gimenez, “Serum oxidative stress parameters of women with hypothyroidism,” Acta Biomedica de l'Ateneo Parmense, vol. 80, no. 2, pp. 135–139, 2009. View at Google Scholar · View at Scopus
  71. E. Akarsu, H. Buyukhatipoglu, Ş. Aktaran, and N. Kurtul, “Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy,” Clinical Endocrinology, vol. 74, no. 1, pp. 118–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. N. Nanda, Z. Bobby, and A. Hamide, “Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference,” Clinical and Experimental Medicine, vol. 8, no. 2, pp. 101–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. B. Rybus-Kalinowska, K. Zwirska-Korczala, M. Kalinowski, M. Kukla, E. Birkner, and J. Jochem, “Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism,” Polskie Archiwum Medycyny Wewnetrznej, vol. 118, no. 7-8, pp. 420–425, 2008. View at Google Scholar · View at Scopus
  74. Ü. Öztürk, P. Vural, A. Özderya et al., “Oxidative stress parameters in serum and low density lipoproteins of Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism,” International Immunopharmacology, vol. 14, no. 4, pp. 349–352, 2012. View at Google Scholar
  75. J. Bednarek, H. Wysocki, and J. Sowinski, “Oxidation products and antioxidant markers in plasma of patients with Graves' disease and toxic multinodular goiter: effect of methimazole treatment,” Free Radical Research, vol. 38, no. 6, pp. 659–664, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Haribabu, V. S. Reddy, Ch. Pallavi et al., “Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism,” Endocrine, vol. 44, no. 1, pp. 152–157, 2013. View at Google Scholar
  77. E. Carmeli, A. Bachar, S. Barchad, M. Morad, and J. Merrick, “Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: a pilot study,” Research in Developmental Disabilities, vol. 29, no. 5, pp. 431–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Erdamar, H. Demirci, H. Yaman et al., “The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status,” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 7, pp. 1004–1010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. A. S. R. Araujo, F. E. R. Seibel, T. Fernandes, S. Llesuy, L. Kucharski, and A. Belló-Klein, “Thyroid hormone-induced haemoglobin changes and antioxidant enzymes response in erythrocytes,” Cell Biochemistry and Function, vol. 29, no. 5, pp. 408–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Yücel, S. Özdemir, N. DarIyerli, S. Toplan, M. C. Akyolcu, and G. Yiǧit, “Erythrocyte osmotic fragility and lipid peroxidation in experimental hyperthyroidism,” Endocrine, vol. 36, no. 3, pp. 498–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Branter, N. Drescher, M. Padilla, and L. A. Trepanier, “Antioxidant status in hyperthyroid cats before and after radioiodine treatment,” Journal of Veterinary Internal Medicine, vol. 26, no. 3, pp. 582–588, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. S. O. Rahaman, S. Ghosh, K. P. Mohanakumar, S. Das, and P. Kumar Sarkar, “Hypothyroidism in the developing rat brain is associated with marked oxidative stress and aberrant intraneuronal accumulation of neurofilaments,” Neuroscience Research, vol. 40, no. 3, pp. 273–279, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. O. M. Ahmed, R. G. Ahmed, A. W. El-Gareib, A. M. El-Bakry, and S. M. Abd El-Tawab, “Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring—II. The developmental pattern of neurons in relation to oxidative stress and antioxidant defense system,” International Journal of Developmental Neuroscience, vol. 30, no. 6, pp. 517–537, 2012. View at Google Scholar
  84. S. Jena, J. Dandapat, and G. B. N. Chainy, “Curcumin differentially regulates the expression of superoxide dismutase in cerebral cortex and cerebellum of l-thyroxine (T4)-induced hyperthyroid rat brain,” Neurological Sciences, vol. 34, no. 4, pp. 505–510, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Jena, C. Anand, G. B. N. Chainy, and J. Dandapat, “Induction of oxidative stress and inhibition of superoxide dismutase expression in rat cerebral cortex and cerebellum by PTU-induced hypothyroidism and its reversal by curcumin,” Neurological Sciences, vol. 33, no. 4, pp. 869–873, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Mano, R. Sinohara, Y. Sawai et al., “Changes in lipid peroxidation and free radical scavengers in the brain of hyper- and hypothyroid aged rats,” Journal of Endocrinology, vol. 147, no. 2, pp. 361–365, 1995. View at Google Scholar · View at Scopus
  87. S. Bhanja and S. Jena, “Modulation of antioxidant enzyme expression by PTU-induced hypothyroidism in cerebral cortex of postnatal rat brain,” Neurochemical Research, vol. 38, no. 1, pp. 42–49, 2013. View at Google Scholar
  88. E. Cano-Europa, F. Pérez-Severiano, P. Vergara et al., “Hypothyroidism induces selective oxidative stress in amygdala and hippocampus of rat,” Metabolic Brain Disease, vol. 23, no. 3, pp. 275–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Cattani, P. B. Goulart, V. L. Cavalli et al., “Congenital hypothyroidism alters the oxidative status, enzyme activities and morphological parameters in the hippocampus of developing rats,” Molecular and Cell Endocrinology, vol. 375, no. 1-2, pp. 14–26, 2013. View at Google Scholar
  90. S. Bhanja and G. B. N. Chainy, “PTU-induced hypothyroidism modulates antioxidant defence status in the developing cerebellum,” International Journal of Developmental Neuroscience, vol. 28, no. 3, pp. 251–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. J. H. Oppenheimer, H. L. Schwartz, and M. I. Surks, “Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen and testis,” Endocrinology, vol. 95, no. 3, pp. 897–903, 1974. View at Google Scholar · View at Scopus
  92. T. Esaki, H. Suzuki, M. Cook et al., “Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors,” Endocrinology, vol. 144, no. 9, pp. 4117–4122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Pacheco-Rosado, G. Arias-Citalán, R. Ortiz-Butrón, and L. Rodríquez-Páez, “Selective decrease of Na+/K+ -ATPase activity in the brain of hypothyroid rats,” Proceedings of the Western Pharmacology Society, vol. 48, pp. 52–54, 2005. View at Google Scholar
  94. R. R. Rajan and S. S. Katyare, “Effect of 3,5,3′-tri-iodothyronine on cellular growth and oxygen consumption in neonatal rat brain,” Experientia, vol. 38, no. 9, pp. 1110–1114, 1982. View at Google Scholar · View at Scopus
  95. P. M. Yen, “Physiological and molecular basis of Thyroid hormone action,” Physiological Reviews, vol. 81, no. 3, pp. 1097–1142, 2001. View at Google Scholar · View at Scopus
  96. E. Cadenas, A. I. Varsavsky, A. Boveris, and B. Chance, “Oxygen- or organic hydroperoxide-induced chemiluminescence of brain and liver homogenates,” Biochemical Journal, vol. 198, no. 3, pp. 645–654, 1981. View at Google Scholar · View at Scopus
  97. G. S. Rai, T. Gluck, and S. Luttrell, “Clinical presentation of hypothyroidism in older persons,” Journal of the American Geriatrics Society, vol. 43, no. 5, pp. 592–593, 1995. View at Google Scholar · View at Scopus
  98. L. M. Roberts, H. Pattison, A. Roalfe et al., “Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction?” Annals of Internal Medicine, vol. 145, no. 8, pp. 573–581, 2006. View at Google Scholar · View at Scopus
  99. A. W. Van Den Beld, T. J. Visser, R. A. Feelders, D. E. Grobbee, and S. W. J. Lamberts, “Thyroid hormone concentrations, disease, physical function, and mortality in elderly men,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6403–6409, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. L. Boucai and M. I. Surks, “Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice,” Clinical Endocrinology, vol. 70, no. 5, pp. 788–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. M. I. Surks and L. Boucai, “Age- and race-based serum thyrotropin reference limits,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 496–502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. V. B. Chueire, J. H. Romaldini, and L. S. Ward, “Subclinical hypothyroidism increases the risk for depression in the elderly,” Archives of Gerontology and Geriatrics, vol. 44, no. 1, pp. 21–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. R. T. Joffe, E. N. Pearce, J. V. Hennessey, J. J. Ryan, and R. A. Stern, “Subclinical hypothyroidism, mood, and cognition in older adults: a review,” International Journal of Geriatric Psychiatry, vol. 28, no. 2, pp. 111–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. P. W. Rosario, A. C. M. Xavier, and M. R. Calsolari, “TSH reference values for adult Brazilian population,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 54, no. 7, pp. 603–606, 2010. View at Google Scholar · View at Scopus
  105. M. P. J. Van Boxtel, P. P. C. A. Menheere, O. Bekers, E. Hogervorst, and J. Jolles, “Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study,” Psychoneuroendocrinology, vol. 29, no. 7, pp. 891–898, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. Å. Wahlin, D. Bunce, and T.-B. R. Wahlin, “Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age,” Psychoneuroendocrinology, vol. 30, no. 7, pp. 625–637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. A. S. Artis, S. Bitiktas, E. Taşkin, N. Dolu, N. Liman, and C. Suer, “Experimental hypothyroidism delays field excitatory post-synaptic potentials and disrupts hippocampal long-term potentiation in the dentate gyrus of hippocampal formation and Y-maze performance in adult rats,” Journal of Neuroendocrinology, vol. 24, no. 3, pp. 422–433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. D. Osterweil, K. Syndulko, S. N. Cohen et al., “Cognitive function in non-demented older adults with hypothyroidism,” Journal of the American Geriatrics Society, vol. 40, no. 4, pp. 325–335, 1992. View at Google Scholar · View at Scopus
  109. M. H. Samuels, K. G. Schuff, N. E. Carlson, P. Carello, and J. S. Janowsky, “Health status, mood, and cognition in experimentally induced subclinical hypothyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 7, pp. 2545–2551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Vogel, T. V. Elberling, M. Hørding et al., “Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis,” Psychoneuroendocrinology, vol. 32, no. 1, pp. 36–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. J. D. Davis and G. Tremont, “Neuropsychiatric aspects of hypothyroidism and treatment reversibility,” Minerva Endocrinologica, vol. 32, no. 1, pp. 49–65, 2007. View at Google Scholar · View at Scopus
  112. K. H. Alzoubi, N. Z. Gerges, A. M. Aleisa, and K. A. Alkadhi, “Levothyroxin restores hypothyroidism-induced impairment of hippocampus-dependent learning and memory: behavioral, electrophysiological, and molecular studies,” Hippocampus, vol. 19, no. 1, pp. 66–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. J. W. Smith, A. T. Evans, B. Costall, and J. W. Smythe, “Thyroid hormones, brain function and cognition: a brief review,” Neuroscience and Biobehavioral Reviews, vol. 26, no. 1, pp. 45–60, 2002. View at Publisher · View at Google Scholar · View at Scopus
  114. R. Kapoor, L. A. Desouza, I. N. Nanavaty, S. G. Kernie, and V. A. Vaidya, “Thyroid hormone accelerates the differentiation of adult hippocampal progenitors,” Journal of Neuroendocrinology, vol. 24, no. 9, pp. 1259–1271, 2012. View at Google Scholar
  115. J. Sala-Roca, E. Estebanez-Perpina, F. Balada, A. Garau, and M. A. Martí-Carbonell, “Effects of adult dysthyroidism on the morphology of hippocampal neurons,” Behavioural Brain Research, vol. 188, no. 2, pp. 348–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. M. A. Martí-Carbonell, A. Garau, J. Sala-Roca, and F. Balada, “Effects of adult dysthyroidism on the morphology of hippocampal granular cells in rats,” Acta Neurobiologiae Expperimentalis, vol. 72, no. 3, pp. 230–239, 2012. View at Google Scholar
  117. J. Pacheco-Rosado, S. Zamudio-Hernández, and G. Chambert, “Thyroid hormones modify susceptibility to lidocaine-kindling in rats,” Life Sciences, vol. 69, no. 22, pp. 2575–2582, 2001. View at Google Scholar · View at Scopus
  118. C. Alva-Sánchez, R. Ortiz-Butrón, and J. Pacheco-Rosado, “Kainic acid does not affect CA3 hippocampal region pyramidal cells in hypothyroid rats,” Brain Research Bulletin, vol. 63, no. 2, pp. 167–171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Alva-Sánchez, K. Sánchez-Huerta, O. Arroyo-Helguera, B. Anguiano, C. Aceves, and J. Pacheco-Rosado, “The maintenance of hippocampal pyramidal neuron populations is dependent on the modulation of specific cell cycle regulators by thyroid hormones,” Brain Research, vol. 1271, pp. 27–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. R. T. De Jongh, P. Lips, N. M. Van Schoor et al., “Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals,” European Journal of Endocrinology, vol. 165, no. 4, pp. 545–554, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. M. K. Moon, Y. J. Lee, S. H. Choi et al., “Subclinical hypothyroidism has little influences on muscle mass or strength in elderly people,” Journal of Korean Medical Science, vol. 25, no. 8, pp. 1176–1181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. J. Bowers, J. Terrien, M. S. Clerget-Froidevaux et al., “Thyroid hormone signaling and homeostasis during aging,” Endocrine Reviews, vol. 34, no. 4, pp. 556–589, 2013. View at Google Scholar
  123. G. F. Lewis, C. A. Alessi, J. G. Imperial, and S. Refetoff, “Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression,” Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 4, pp. 843–849, 1991. View at Google Scholar · View at Scopus
  124. R. I. Gregerman, G. W. Gaffney, N. W. Shock, and S. E. Crowder, “Thyroxine turnover in euthyroid man with special reference to changes with age,” The Journal of Clinical Investigation, vol. 41, pp. 2065–2074, 1962. View at Google Scholar · View at Scopus
  125. C. T. Sawin, A. Geller, P. A. Wolf et al., “Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons,” New England Journal of Medicine, vol. 331, no. 19, pp. 1249–1252, 1994. View at Publisher · View at Google Scholar · View at Scopus
  126. E. H. Gan and S. H. Pearce, “Clinical review: the thyroid in mind: cognitive function and low thyrotropin in older people,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 10, pp. 3438–3449, 2012. View at Google Scholar
  127. M. Schrag, C. Mueller, M. Zabel et al., “Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis,” Neurobiology of Disease, vol. 59, pp. 100–110, 2013. View at Google Scholar
  128. G. T. Sutherland, B. Chami, P. Youssef, and P. K. Witting, “Oxidative stress in Alzheimer's disease: primary villain or physiological by-product?” Redox Report, vol. 18, no. 4, pp. 134–141, 2013. View at Google Scholar
  129. M. F. Beal, “Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment,” Journal of Bioenergetics and Biomembranes, vol. 36, no. 4, pp. 381–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. D. A. Butterfield, T. Reed, S. F. Newman, and R. Sultana, “Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment,” Free Radical Biology and Medicine, vol. 43, no. 5, pp. 658–677, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. R. Sultana and D. A. Butterfield, “Role of oxidative stress in the progression of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 19, no. 1, pp. 341–353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. F. Di Domenico, R. Coccia, D. A. Butterfield, and M. Perluigi, “Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits,” Biochimica et Biophysica Acta, vol. 1814, no. 12, pp. 1785–1795, 2011. View at Publisher · View at Google Scholar · View at Scopus
  133. S. Kalmijn, K. M. Mehta, H. A. P. Pols, A. Hofman, H. A. Drexhage, and M. M. B. Breteler, “Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study,” Clinical Endocrinology, vol. 53, no. 6, pp. 733–737, 2000. View at Publisher · View at Google Scholar · View at Scopus
  134. L. A. D. M. Van Osch, E. Hogervorst, M. Combrinck, and A. D. Smith, “Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease,” Neurology, vol. 62, no. 11, pp. 1967–1971, 2004. View at Google Scholar · View at Scopus
  135. F. Yoshimasu, E. Kokmen, I. D. Hay, C. M. Beard, K. P. Offord, and L. T. Kurland, “The association between Alzheimer's disease and thyroid disease in Rochester, Minnesota,” Neurology, vol. 41, no. 11, pp. 1745–1747, 1991. View at Google Scholar · View at Scopus
  136. L. Cárdenas-Ibarra, J. A. Solano-Velázquez, R. Salinas-Martínez, T. D. Aspera-Ledezma, M. D. R. Sifuentes-Martínez, and J. Z. Villarreal-Pérez, “Cross-sectional observations of thyroid function in geriatric Mexican outpatients with and without dementia,” Archives of Gerontology and Geriatrics, vol. 46, no. 2, pp. 173–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  137. G. Ceresini, F. Lauretani, M. Maggio et al., “Thyroid function abnormalities and cognitive impairment in elderly people: results of the invecchiare in chianti study,” Journal of the American Geriatrics Society, vol. 57, no. 1, pp. 89–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. D. L. Ewins, M. N. Rossor, J. Butler, P. K. Roques, M. J. Mullan, and A. M. McGregor, “Association between autoimmine thyroid disease and familial Alzheimers disease,” Clinical Endocrinology, vol. 35, no. 1, pp. 93–96, 1991. View at Google Scholar · View at Scopus
  139. O. L. Lopez, B. S. Rabin, F. J. Huff, D. Rezek, and O. M. Reinmuth, “Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects,” Stroke, vol. 23, no. 8, pp. 1078–1083, 1992. View at Google Scholar · View at Scopus
  140. M. Ganguli, L. A. Burmeister, E. C. Seaberg, S. Belle, and S. T. DeKosky, “Association between dementia and elevated TSH: a community-based study,” Biological Psychiatry, vol. 40, no. 8, pp. 714–725, 1996. View at Publisher · View at Google Scholar · View at Scopus
  141. F. J. De Jong, T. Den Heijer, T. J. Visser et al., “Thyroid hormones, dementia, and atrophy of the medial temporal lobe,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 7, pp. 2569–2573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  142. M. K. Sutherland, L. Wong, M. J. Somerville et al., “Reduction of thyroid hormone receptor c-ERB Aα mRNA levels in the hippocampus of Alzheimer as compared to Huntington brain,” Neurobiology of Aging, vol. 13, no. 2, pp. 301–312, 1992. View at Publisher · View at Google Scholar · View at Scopus
  143. L. Goumidi, F. Flamant, C. Lendon et al., “Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's disease,” Neurobiology of Aging, vol. 32, no. 4, pp. 624–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. C. Contreras-Jurado and A. Pascual, “Thyroid hormone regulation of APP (β-amyloid precursor protein) gene expression in brain and brain cultured cells,” Neurochemistry International, vol. 60, no. 5, pp. 484–487, 2012. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Belakavadi, J. Dell, G. J. Grover, and J. D. Fondell, “Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events,” Molecular and Cellular Endocrinology, vol. 339, no. 1-2, pp. 72–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. A. L. Fu, C. Y. Zhou, and X. Chen, “Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease,” Neuropharmacology, vol. 58, no. 4-5, pp. 722–729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. E. Ishida, K. Hashimoto, S. Okada et al., “Crosstalk between thyroid hormone receptor and liver X receptor in the regulation of selective Alzheimer's disease indicator-1 gene expression,” PLoS ONE, vol. 8, no. 1, Article ID e54901, 2013. View at Google Scholar
  148. M. Martin, C. G. Dotti, and M. D. Ledesma, “Brain cholesterol in normal and pathological aging,” Biochimica et Biophysica Acta, vol. 1801, no. 8, pp. 934–944, 2010. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Fiorini, T. Koudriavtseva, E. Bucaj et al., “Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis,” PLoS ONE, vol. 8, no. 6, Article ID e65184, 2013. View at Google Scholar
  150. E. Miller, B. Wachowicz, and I. Majsterek, “Advances in antioxidative therapy of multiple sclerosis,” Current Medicinal Chemistry, 2013. View at Google Scholar
  151. A. Van der Goes, D. Wouters, S. M. Van Der Pol et al., “Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro,” The FASEB Journal, vol. 15, no. 10, pp. 1852–1854, 2001. View at Google Scholar · View at Scopus
  152. T. Mronga, T. Stahnke, O. Goldbaum, and C. Richter-Landsberg, “Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes,” GLIA, vol. 46, no. 4, pp. 446–455, 2004. View at Publisher · View at Google Scholar · View at Scopus
  153. J. van Horssen, G. Schreibelt, J. Drexhage et al., “Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression,” Free Radical Biology and Medicine, vol. 45, no. 12, pp. 1729–1737, 2008. View at Publisher · View at Google Scholar · View at Scopus
  154. G. G. Ortiz, M. Á. Macías-Islas, F. P. Pacheco-Moisés et al., “Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis,” Disease Markers, vol. 26, no. 1, pp. 35–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  155. N. Baumann and D. Pham-Dinh, “Biology of oligodendrocyte and myelin in the mammalian central nervous system,” Physiological Reviews, vol. 81, no. 2, pp. 871–927, 2001. View at Google Scholar · View at Scopus
  156. C. M. Acosta, C. Cortes, H. Macphee, and M. P. Namaka, “Exploring the role of nerve growth factor in multiple sclerosis: implications in myelin repair,” CNS & Neurological Disorders Drug Targets, 2013. View at Google Scholar
  157. W. Wong, J. Xiao, D. Kemper, T. J. Kilpatrick, and S. S. Murray, “Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferation,” The Journal of Neurosciece, vol. 33, no. 11, pp. 4947–4949, 2013. View at Google Scholar
  158. G. Almazan, P. Honegger, and J.-M. Matthieu, “Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study,” Developmental Neuroscience, vol. 7, no. 1, pp. 45–54, 1985. View at Google Scholar · View at Scopus
  159. N. R. Jagannathan, N. Tandon, P. Raghunathan, and N. Kochupillai, “Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study,” Developmental Brain Research, vol. 109, no. 2, pp. 179–186, 1998. View at Publisher · View at Google Scholar · View at Scopus
  160. M. Fernandez, A. Giuliani, S. Pirondi et al., “Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 46, pp. 16363–16368, 2004. View at Publisher · View at Google Scholar · View at Scopus
  161. A. Rodriguez-Pena, N. Ibarrola, M. A. Iniguez, A. Munoz, and J. Bernal, “Neonatal hypothyroidism affects the timely expression of myelin- associated glycoprotein in the rat brain,” Journal of Clinical Investigation, vol. 91, no. 3, pp. 812–818, 1993. View at Google Scholar · View at Scopus
  162. P. C. Barradas, R. S. Vieira, and M. S. De Freitas, “Selective effect of hypothyroidism on expression of myelin markers during development,” Journal of Neuroscience Research, vol. 66, no. 2, pp. 254–261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  163. J. C. Dugas, A. Ibrahim, and B. A. Barres, “The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration,” Molecular and Cellular Neuroscience, vol. 50, no. 1, pp. 45–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  164. P. G. Franco, L. Silvestroff, E. F. Soto, and J. M. Pasquini, “Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination,” Experimental Neurology, vol. 212, no. 2, pp. 458–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  165. A. Karni and O. Abramsky, “Association of MS with thyroid disorders,” Neurology, vol. 53, no. 4, pp. 883–885, 1999. View at Google Scholar · View at Scopus
  166. E. Munteis, J. F. Cano, J. A. Flores, J. E. Martinez-Rodriguez, M. Miret, and J. Roquer, “Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort,” European Journal of Neurology, vol. 14, no. 9, pp. 1048–1052, 2007. View at Publisher · View at Google Scholar · View at Scopus
  167. C. Zhou, Y. Huang, and S. Przedborski, “Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance,” Annals of the New York Academy of Sciences, vol. 1147, pp. 93–104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  168. T. G. Hastings, “The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 6, pp. 469–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. M. S. Motherwell and L. Zuo, “The novel role of mitochondrial induced oxidative stress and genetic mutations in Parkinson's disease,” Gene, 2013. View at Google Scholar
  170. D.-C. Wu, P. Teismann, K. Tieu et al., “NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 6145–6150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  171. H. L. Martin and P. Teismann, “Glutathione—a review on its role and significance in Parkinson's disease,” FASEB Journal, vol. 23, no. 10, pp. 3263–3272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. J. M. García-Moreno and J. Chacón, “Hipotiroidismo enmascarado por enfermedad de Parkinson,” Revista de Neurología, vol. 35, no. 8, pp. 741–742, 2002. View at Google Scholar
  173. T. K. Hee, M. J. Edwards, R. Lakshmi Narsimhan, and K. P. Bhatia, “Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson,” Parkinsonism and Related Disorders, vol. 11, no. 5, pp. 331–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  174. A. C. Johannessen, A. Boye, and H. Pakkenberg, “Thyroid function in patients with Parkinson's disease,” Acta Neurologica Scandinavica, vol. 75, no. 5, pp. 364–365, 1987. View at Google Scholar · View at Scopus
  175. H. Tandeter, A. Levy, G. Gutman, and P. Shvartzman, “Subclinical thyroid disease in patients with Parkinson's disease,” Archives of Gerontology and Geriatrics, vol. 33, no. 3, pp. 295–300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  176. R. P. Munhoz, H. A. G. Teive, A. R. Troiano et al., “Parkinson's disease and thyroid dysfunction,” Parkinsonism and Related Disorders, vol. 10, no. 6, pp. 381–383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  177. U. Bonuccelli, C. D'Avino, N. Caraccio et al., “Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients,” Parkinsonism and Related Disorders, vol. 5, no. 1-2, pp. 49–53, 1999. View at Publisher · View at Google Scholar · View at Scopus